Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAOX | Q6QHF9 | 3/20 | 0.48 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.46 |
| ▸ | KDM4A | O75164 | 1/20 | 0.46 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.46 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | KDM1A | O60341 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1783020 | 0.97 | PAOX (0.52) | PAOXKDM4CKDM4APHF8KDM2A | |
| SCHEMBL20411505 | 0.97 | PAOX (0.52) | PAOXKDM4CKDM4APHF8KDM2A | |
| SCHEMBL1782645 | 0.97 | PAOX (0.52) | PAOXKDM4CKDM4APHF8KDM2A | |
| SCHEMBL16431234 | 0.97 | PAOX (0.52) | PAOXKDM4CKDM4APHF8KDM2A | |
| SCHEMBL18314426 | 0.97 | PAOX (0.52) | PAOXKDM4CKDM4APHF8KDM2A | |
| SCHEMBL8896028 | 0.97 | PAOX (0.52) | PAOXKDM4CKDM4APHF8KDM2A | |
| SCHEMBL15026773 | 0.97 | PAOX (0.52) | PAOXKDM4CKDM4APHF8KDM2A | |
| SCHEMBL12526756 | 0.97 | PAOX (0.52) | PAOXKDM4CKDM4APHF8KDM2A | |
| SCHEMBL7542023 | 0.92 | — | — | |
| SCHEMBL130602 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117904435-A | Solvent extraction system for separating zirconium and hafnium, preparation method thereof and separation method of zirconium and hafnium | 北京科技大学 | 2024-04-19 | — | — | CN | claimed |
| US-10685844-B2 | Hardmask composition, method of forming pattern by using the hardmask composition, and hardmask formed using the hardmask composition | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-06-16 | — | — | US | claimed |
| US-20190035635-A1 | HARDMASK COMPOSITION, METHOD OF FORMING PATTERN BY USING THE HARDMASK COMPOSITION, AND HARDMASK FORMED USING THE HARDMASK COMPOSITION | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-01-31 | — | — | US | claimed |
| WO-2018152759-A1 | STRETCHABLE CONDUCTIVE PASTE COMPOSITION | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2018-08-30 | — | — | WO | claimed |
| CN-119552065-A | Method for preparing multi-carbon methyl ketone from acetone | 万华化学集团股份有限公司 | 2025-03-04 | — | — | CN | disclosed |
| US-12222653-B2 | Method for forming semiconductor structure | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2025-02-11 | — | — | US | disclosed |
| US-20250000088-A1 | ANT CONTROL AGENT AND ANT CONTROL METHOD | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-01-02 | — | — | US | disclosed |
| EP-4424164-A1 | ANT CONTROL AGENT AND ANT CONTROL METHOD | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-09-04 | — | — | EP | disclosed |
| CN-115551839-B | Heteroaryl-triazole compounds as pesticides | 拜耳公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-118139527-A | Ant control agent and ant control method | 信越化学工业株式会社 | 2024-06-04 | — | — | CN | disclosed |
| US-20240158375-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS | Azura Ophthalmics Ltd. (IL) | 2024-05-16 | — | — | US | disclosed |
| CN-118020018-A | Ophthalmic device and method of manufacture | 博士伦爱尔兰有限公司 | 2024-05-10 | — | — | CN | disclosed |
| EP-0310321-B1 | Immunomodulatory azaspiranes | SMITHKLINE BEECHAM CORP (US) | 1994-11-30 | — | — | EP | disclosed |
| US-5215818-A | Pressure-sensitive adhesive comprising solid tacky microspheres and macromonomer-containing binder copolymer | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-06-01 | — | — | US | disclosed |
| US-5118750-A | PRESSURE-SENSITIVE ADHESIVE COMPRISING SOLID TACKY MICROSPHERES AND MACROMONOMER-CONTAINING BINDER COPOLYMER | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1992-06-02 | — | — | US | disclosed |
| EP-0454365-A2 | Pressure sensitive adhesive comprising tacky microspheres and macromonomer-containing binder copolymer | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1991-10-30 | — | — | EP | disclosed |
| EP-0419020-A1 | Pressure-sensitive adhesive comprising hollow tacky microspheres and macromonomer-containing binder copolymer | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1991-03-27 | — | — | EP | disclosed |
| US-4994322-A | Repositionable | MINNESOTA MINING AND MANUFACTURING (US) | 1991-02-19 | — | — | US | disclosed |
| US-4960779-A | Pyrrole derivatives, and pharmaceutical compositions which contain them and pharmacological methods of use | RHONE-POULENC SANTE (FR) | 1990-10-02 | — | — | US | disclosed |
| EP-0310321-A2 | Immunomodulatory azaspiranes | SMITHKLINE BEECHAM CORPORATION (US) | 1989-04-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190035635-A1 | HARDMASK COMPOSITION, METHOD OF FORMING PATTERN BY USING THE HARDMASK COMPOSITION, AND HARDMASK FORMED USING THE HARDMASK COMPOSITION | DEK, HNRNPK, DGKA | PAOX 2318/4885KDM4C 3883/4885KDM4A 3662/4885 |
| US-20240158375-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS | MPO, MUC1, CRYAB | PAOX 898/4885KDM4C 2950/4885KDM4A 3122/4885 |
| US-10685844-B2 | Hardmask composition, method of forming pattern by using the hardmask composition, and hardmask formed using the hardmask composition | DEK, HNRNPK, DGKA | PAOX 2318/4885KDM4C 3883/4885KDM4A 3662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.